Evidence map›Paper›PMID 38175920›Full record

ArticleAmerican journal of respiratory and critical care medicine2024

Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry.

Andrew I Ritchie, Gavin C Donaldson, Eric A Hoffman, James P Allinson, Chloe I Bloom, Charlotte E Bolton, Gourab Choudhury, Sarah E Gerard, Junfeng Guo, Luana Alves-Moreira and 17 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
20.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Definitions of early COPD and predictors for disease progression: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Pre-COPD: Impact on prevention, detection, and treatment.Presse medicale (Paris, France : 1983) · 2026
    Review
  13. Review
  14. Article
  15. Small Airway Disease in Pre-COPD and Early COPD: Insights Into the Pulmonary "Silent Zone".International journal of chronic obstructive pulmonary disease · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 16 institutions in 8 countries.

Andrew I RitchieNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Gavin C DonaldsonNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Eric A HoffmanDepartment of Radiology and.ORCID 0000-0001-8456-9437
James P AllinsonNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Chloe I BloomNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Charlotte E BoltonNIHR Nottingham Biomedical Research Centre.
Gourab ChoudhuryELEGI and COLT Laboratories, Queen's Medical Research Institute, Edinburgh, United Kingdom.
Sarah E GerardRoy J. Carver Department of Biomedical Engineering, Medicine and Biomedical Engineering, University of Iowa, Iowa City, Iowa.
Junfeng GuoDepartment of Radiology and.
Luana Alves-MoreiraNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Lorcan McGarveyWellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.
Elizabeth SapeyInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.ORCID 0000-0003-3454-5482
Robert A StockleyInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
K P YipInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.
Dave SinghDivision of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom.
Tom WilkinsonFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Malin FagerasAstraZeneca, Gothenburg, Sweden.
Kristoffer OstridgeFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Olaf JönsBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Enrica BucchioniChiesi Farmaceutici S.p.A., Parma, Italy.
Chris H ComptonGlaxoSmithKline, Brentford, United Kingdom.
Paul JonesGlaxoSmithKline, Brentford, United Kingdom.
Karen MezziNovartis Pharma AG, Basel, Switzerland; and.
Jørgen VestboDivision of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom.ORCID 0000-0001-6355-6362
Peter M A CalverleyInstitute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
Jadwiga A WedzichaNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
British Early COPD Network (BEACON) Cohort Investigators
British Lung Foundation · GBAstraZeneca (Sweden) · SEBoehringer Ingelheim (Egypt) · EGBoehringer Ingelheim (Germany) · DEGlaxoSmithKline (United Kingdom) · GBUniversity of Birmingham · GBUniversity of Iowa · USUniversity of Manchester · GBAstraZeneca (United Kingdom) · GBNovartis (Switzerland) · CHQueen's University Belfast · GBRoyal Brompton Hospital · GBThe Queen's Medical Research Institute · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Liverpool · GBUniversity of Nottingham · GB

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
NCI NIH HHS P30 CA086862NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605NIH HHS HL-11298
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LungPulmonary Disease, Chronic ObstructiveSpirometryTomography, X-Ray ComputedAdultCase-Control StudiesDisease ProgressionFemaleForced Expiratory VolumeHumansMaleMiddle AgedSmokersSmokingYoung Adultchronic obstructive pulmonary diseaseearly COPDFEV1lung functionquantitative computed tomography

Identifiers

PMID38175920
PMCPMC11146542
OpenAlexW4390577027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.